Suchergebnisse - "d'Arminio Monforte, Antonella"

PubPharm (42)

1

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens : A Prospective RESPOND Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Álvarez, H. | Mocroft, A. | Ryom, L. | +130

2

The symptomatology of cerebrospinal fluid HIV RNA escape : a large case-series

enthalten in: AIDS (London, England) | 2021

von Chan, T. | De Zan, V. | Gregg, A. | +12

3

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen : The "STORE" Study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2020

von Gori, A. | Antinori, A. | Vergori, A. | +22

4

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities : is it time to assess the definitions?

enthalten in: AIDS (London, England) | 2019

von Trunfio, M. | Pinnetti, C. | Focà, E. | +10

5

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2) : week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

enthalten in: Lancet (London, England) | 2019

von Cahn, P. | Madero, J. | Arribas, J. | +118

CommentIn: Lancet. 2019 Jan 12;393(10167):106-108. - PMID 30420122

6

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

enthalten in: HIV medicine | 2018

von Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord | Monge, S. | Mocroft, A. | +98

7

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients

enthalten in: PloS one | 2017

von Gianotti, N. | Cozzi-Lepri, A. | Antinori, A. | +11

8

Improvement of ALT decay kinetics by all-oral HCV treatment : Role of NS5A inhibitors and differences with IFN-based regimens

enthalten in: PloS one | 2017

von Cento, V. | Nguyen, T. | Di Carlo, D. | +38

9

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients : A Cohort Study

enthalten in: Annals of internal medicine | 2017

von Wang, Q. | De Luca, A. | Smith, C. | +105

CommentIn: Ann Intern Med. 2017 Jan 3;166(1):69-70. - PMID 27750296

10

Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

enthalten in: The Journal of antimicrobial chemotherapy | 2016

von Galli, L. | Spagnuolo, V. | Bigoloni, A. | +55

1
2
3
4
5
Nächster »
[5]